{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:03Z","timestamp":1791996783052,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970757"],"award-info":[{"award-number":["81970757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270938"],"award-info":[{"award-number":["82270938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-XHXX-009"],"award-info":[{"award-number":["2025-I2M-XHXX-009"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-PT320-10"],"award-info":[{"award-number":["2023-PT320-10"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bone.2026.118015","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:17:45Z","timestamp":1784215065000},"page":"118015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of etoricoxib on bone microarchitecture in PHO patients: A 12-month longitudinal study assessed by HR-pQCT"],"prefix":"10.1016","volume":"212","author":[{"given":"Ruotong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Jiajue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4028-5560","authenticated-orcid":false,"given":"Qianqian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.118015_bb0005","doi-asserted-by":"crossref","first-page":"1235040","DOI":"10.3389\/fendo.2023.1235040","article-title":"Primary hypertrophic osteoarthropathy: genetics, clinical features and management","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.bone.2026.118015_bb0010","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.7150\/ijbs.71261","article-title":"Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations","volume":"18","author":"Lu","year":"2022","journal-title":"Int. Aust. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.bone.2026.118015_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal","year":"2008","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bone.2026.118015_bb0020","doi-asserted-by":"crossref","first-page":"E923","DOI":"10.1210\/jc.2012-3568","article-title":"Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization","volume":"98","author":"Zhang","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118015_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2017.09.015","article-title":"Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): a single-center study","volume":"106","author":"Hou","year":"2018","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2026.118015_bb0030","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jbmr.4310","article-title":"Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy","volume":"36","author":"Xu","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2026.118015_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00774-007-0808-2","article-title":"Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL\/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells","volume":"26","author":"Taketa","year":"2008","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.bone.2026.118015_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0188-4409(01)00251-X","article-title":"Primary hypertrophic osteoarthropathy: clinical, radiologic, and scintigraphic characteristics","volume":"32","author":"Jajic","year":"2001","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118015_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11684-013-0246-6","article-title":"Primary hypertrophic osteoarthropathy: an update","volume":"7","author":"Zhang","year":"2013","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.bone.2026.118015_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","article-title":"Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2","volume":"296","author":"Riendeau","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2026.118015_bb0055","doi-asserted-by":"crossref","first-page":"1053999","DOI":"10.3389\/fgene.2022.1053999","article-title":"Etoricoxib as a treatment of choice for patients with <i>SLCO2A1<\/i> mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: a case report","volume":"13","author":"Albawa\u2019neh","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bone.2026.118015_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jot.2018.10.001","article-title":"Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: a single-arm intervention trial","volume":"18","author":"Yuan","year":"2019","journal-title":"J. Orthop. Translat."},{"issue":"8","key":"10.1016\/j.bone.2026.118015_bb0065","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jbmr.3157","article-title":"Clinical, biochemical, and genetic features of 41 Han Chinese families with primary hypertrophic osteoarthropathy, and their therapeutic response to Etoricoxib: results from a six-month prospective clinical intervention","volume":"32","author":"Li","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.118015_bb0070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jbmr.4488","article-title":"Bone geometry, density, microstructure, and biomechanical properties in the distal tibia in patients with primary hypertrophic osteoarthropathy assessed by second-generation high-resolution peripheral quantitative computed tomography","volume":"37","author":"Pang","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2026.118015_bb0075","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00296-014-3037-8","article-title":"Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up","volume":"34","author":"T\u00fcys\u00fcz","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.bone.2026.118015_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S8756-3282(98)00102-1","article-title":"Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia","volume":"23","author":"Ke","year":"1998","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2026.118015_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/8756-3282(94)90272-0","article-title":"Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats","volume":"15","author":"Lin","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.118015_bb0090","first-page":"325","article-title":"Sensory nerve EP4 facilitates heterotopic ossification by regulating angiogenesis-coupled bone formation","volume":"49","author":"Lin","year":"2024","journal-title":"J. Orthop. Transl."},{"issue":"8","key":"10.1016\/j.bone.2026.118015_bb0095","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00198-023-06784-w","article-title":"Comparison of bone microstructure and strength in the distal radius and tibia between the different types of primary hypertrophic osteoarthropathy: an HR-pQCT study","volume":"34","author":"Pang","year":"2023","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2026.118015_bb0100","first-page":"372","article-title":"Continuous infusion of PGE2 is catabolic with a negative bone balance on both cancellous and cortical bone in rats","volume":"7","author":"Tian","year":"2007","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"6","key":"10.1016\/j.bone.2026.118015_bb0105","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bone.2012.03.003","article-title":"Quality control for bone quality parameters affected by subject motion in high-resolution peripheral quantitative computed tomography","volume":"50","author":"Pauchard","year":"2012","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2026.118015_bb0110","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","article-title":"Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography","volume":"31","author":"Whittier","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2026.118015_bb0115","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/ard.2009.114512","article-title":"Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT","volume":"69","author":"Fouque-Aubert","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.bone.2026.118015_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00198-019-05168-3","article-title":"Impaired bone microarchitecture in distal interphalangeal joints in patients with primary hypertrophic osteoarthropathy assessed by high-resolution peripheral quantitative computed tomography","volume":"31","author":"Pang","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2026.118015_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009740701772457","article-title":"Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis","volume":"37","author":"Rendina","year":"2008","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.bone.2026.118015_bb0130","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1038\/s41598-017-09671-7","article-title":"Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bone.2026.118015_bb0135","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.bone.2026.118015_bb0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1022350111213","article-title":"The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat","volume":"22","author":"Gilroy","year":"1998","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.bone.2026.118015_bb0145","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1359\/jbmr.1998.13.12.1852","article-title":"Vis-\u00e0-vis cells and the priming of bone formation","volume":"13","author":"Riminucci","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"9727","key":"10.1016\/j.bone.2026.118015_bb0150","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","article-title":"Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study","volume":"375","author":"Zebaze","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bone.2026.118015_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1123\/ijsnem.2013-0258","article-title":"Load-specific physical activity scores are related to tibia bone architecture","volume":"25","author":"Kindler","year":"2015","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"key":"10.1016\/j.bone.2026.118015_bb0160","doi-asserted-by":"crossref","first-page":"1151838","DOI":"10.3389\/fcell.2023.1151838","article-title":"Connexin 43 hemichannels and prostaglandin E(2) release in anabolic function of the skeletal tissue to mechanical stimulation","volume":"11","author":"Zhao","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bone.2026.118015_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41467-018-08097-7","article-title":"Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bone.2026.118015_bb0170","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bone.2007.12.228","article-title":"Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats","volume":"42","author":"Tian","year":"2008","journal-title":"Bone"},{"issue":"14","key":"10.1016\/j.bone.2026.118015_bb0175","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2106\/JBJS.19.01415","article-title":"Risk of nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids","volume":"102","author":"George","year":"2020","journal-title":"J. Bone Joint Surg. Am."},{"issue":"9","key":"10.1016\/j.bone.2026.118015_bb0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00198-006-0142-x","article-title":"The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian multicentre osteoporosis study","volume":"17","author":"Richards","year":"2006","journal-title":"Osteoporos. Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:39:32Z","timestamp":1791995972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S8756328226002413"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118015","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of etoricoxib on bone microarchitecture in PHO patients: A 12-month longitudinal study assessed by HR-pQCT","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118015"}}